So the question is how do we get there? As opposed to trying to generate it organically, I would think Denner wants this sold or worst case a partnership with an competent entity that can maximize the value of this safe, approved, and effective CV drug.
At this point current management has damaged the company so much that anything above $8-10 seems impossible IMO. But anyone buying down here can still get an excellent ROI if we can sell AMRN for $3+ billion.